VHL and neoplasm: Eighty-two to ninety-two per cent of ccRCC primary tumours harbour biallelic inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene due to loss of one copy of chromosome 3p and inactivation of the second allele by mutation, deletion or hypermethylation1,2.